Brand: ProteoGenix

Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade

PX-TA1420-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: IgG1, kappa

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $482.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade

Product name	Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade
Source	CAS 1436390-63-4
Species	Chimeric
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Vadastuximab,h2H12ec,CD33, SIGLEC3,anti-CD33, SIGLEC3
Reference	PX-TA1420
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

Product name	Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade
Source	CAS 1436390-63-4
Species	Chimeric
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Vadastuximab,h2H12ec,CD33, SIGLEC3,anti-CD33, SIGLEC3
Reference	PX-TA1420
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	IgG1-kappa
Clonality	Monoclonal Antibody

General information on Anti-CD33/SIGLEC3[Homo sapiens] (Vadastuximab) Monoclonal Antibody

Vadastuximab has been investigated for the treatment of Acute myeloid leukemia, Myelodysplastic Syndrome, Acute Myelogenous Leukemia, and Acute Promyelocytic Leukemia.

There are no reviews yet.

Be the first to review “Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade

Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade

General information on Anti-CD33/SIGLEC3[Homo sapiens] (Vadastuximab) Monoclonal Antibody

Related products

CD331 Recombinant Protein

Myeloid cell surface antigen CD33(CD33)

Sialic acid-binding Ig-like lectin 15(SIGLEC15)

CD333 / FGFR3, C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Vadastuximab Biosimilar – Anti-CD33, SIGLEC3 mAb – Research Grade

Specifications Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade

Description

General information on Anti-CD33/SIGLEC3[Homo sapiens] (Vadastuximab) Monoclonal Antibody

Documents

Reviews

Related products

CD331 Recombinant Protein

Myeloid cell surface antigen CD33(CD33)

Sialic acid-binding Ig-like lectin 15(SIGLEC15)

CD333 / FGFR3, C-His, recombinant protein

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Vadastuximab Biosimilar - Anti-CD33, SIGLEC3 mAb - Research Grade